封面
市场调查报告书
商品编码
1702372

全球静脉照明设备市场 - 2025 年至 2033 年

Global Vein Illumination Devices Market - 2025-2033

出版日期: | 出版商: DataM Intelligence | 英文 165 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球静脉照明设备市场规模达到 4.5874 亿美元,预计到 2033 年将达到 31.8611 亿美元,在 2025-2033 年预测期内的复合年增长率为 21.3%。

静脉照明设备是一种先进的医疗工具,它使用近红外光、透照或超音波等技术来提高静脉的可见度。它们可以帮助医疗保健专业人员更准确地定位静脉,减少静脉穿刺失败,并提高患者在静脉插入、抽血和注射等过程中的舒适度。它们对于静脉通路困难的患者(例如儿童、老人以及肥胖或慢性病患者)特别有用。

市场动态:

驾驶员和约束装置

微创手术需求不断成长

全球静脉照明设备市场受到人们对微创医疗程序日益增长的偏好的推动,特别是对于老年患者、儿科人群以及静脉难以定位的患者。医院、捐血中心和门诊手术中心对先进医学影像技术的需求也在推动市场成长。

近红外线 (NIR) 和基于超音波的静脉可视化等技术进步有望增加静脉照明设备的采用,从而改善患者护理和手术效率。此外,机器人辅助手术、介入放射学和门诊护理程序的日益普及进一步强调了静脉照明设备在确保手术成功和改善患者预后方面的重要性。

医疗专业人员的意识和培训有限

由于医疗保健专业人员的认识有限且缺乏适当的培训,全球静脉照明设备市场面临挑战。儘管传统触诊技术能够有效减少静脉穿刺失败率并提高病患舒适度,但许多医护人员仍依赖它。

与先进的近红外线和超音波系统相关的学习曲线也对广泛采用构成了挑战。在发展中地区,缺乏结构化的培训计划和实务经验,进一步限制了静脉照明设备与常规医疗程序的整合。

目录

第一章:市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第二章:高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分类的程式码片段
  • 技术片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第三章:动态

  • 影响因素
    • 驱动程式
      • 微创手术需求不断成长
      • 即时照护和家庭医疗保健需求激增
    • 限制
      • 医疗专业人员的意识和培训有限
      • 先进静脉照明设备成本高昂
    • 机会
      • 人工智慧与红外线技术的融合,提高准确性
    • 影响分析

第四章:战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 南美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析:最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第五章:依产品类型

  • 桌面设备
  • 手持装置

第六章:按技术

  • 近红外线(NIR)技术
  • 透照技术
  • 超音波技术

第七章:按应用

  • 静脉穿刺协助
  • 静脉通路
  • 抽血
  • 其他的

第 8 章:按最终用户

  • 医院和诊所
  • 捐血中心
  • 门诊手术中心
  • 学术及研究机构

第九章:区域市场分析与成长机会

  • 北美洲
    • 关键区域特定动态
      • 我们
      • 加拿大
      • 墨西哥
  • 欧洲
    • 关键区域特定动态
      • 德国
      • 英国
      • 法国
      • 西班牙
      • 义大利
      • 欧洲其他地区
  • 南美洲
    • 关键区域特定动态
      • 巴西
      • 阿根廷
      • 南美洲其他地区
  • 亚太
    • 关键区域特定动态
      • 中国
      • 印度
      • 日本
      • 韩国
      • 亚太其他地区
  • 中东和非洲
    • 关键区域特定动态

第十章:竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第 11 章:公司简介

  • AccuVein Inc
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 併购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT分析
  • Christie Medical Holdings, Inc
  • TransLite LLC
  • BLZ Technology Inc
  • VeinSight
  • Near Infrared Imaging, Inc.
  • Cambridge Medical (Venoscope)
  • VueTek Scientific LLC
  • NextVein LLC

第 12 章:假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 13 章:附录

简介目录
Product Code: MD9471

The global vein illumination devices market reached US$ 458.74 million in 2024 and is expected to reach US$ 3,186.11 million by 2033, growing at a CAGR of 21.3% during the forecast period 2025-2033.

Vein illumination devices are advanced medical tools that improve vein visibility using technologies like near-infrared light, transillumination, or ultrasound. They help healthcare professionals locate veins more accurately, reduce failed venipuncture attempts, and improve patient comfort during procedures like IV insertions, blood draws, and injections. They are particularly useful for patients with difficult venous access, such as children, the elderly, and those with obesity or chronic conditions.

Market Dynamics: Drivers & Restraints

Growing Demand for Minimally Invasive Procedures

The global vein illumination devices market is driven by the growing preference for minimally invasive medical procedures, particularly for elderly patients, pediatric populations, and those with difficult-to-locate veins. The demand for advanced medical imaging technologies in hospitals, blood donation centers, and ambulatory surgical centers is also driving market growth.

Technological advancements like near-infrared (NIR) and ultrasound-based vein visualization are expected to increase the adoption of vein illumination devices, improving patient care and procedural efficiency. Moreover, the increasing adoption of robotic-assisted surgeries, interventional radiology, and ambulatory care procedures further underscores the significance of vein illumination devices in ensuring procedural success and improving patient outcomes.

Limited Awareness and Training Among Healthcare Professionals

The global vein illumination devices market faces challenges due to limited awareness and lack of proper training among healthcare professionals. Despite their effectiveness in reducing failed venipuncture attempts and improving patient comfort, many medical practitioners still rely on traditional palpation techniques.

The learning curve associated with advanced near-infrared and ultrasound-based systems also poses a challenge for widespread adoption. In developing regions, there is a lack of structured training programs and hands-on experience, further limiting the integration of vein illumination devices into routine medical procedures.

Segment Analysis

The global vein illumination devices market is segmented based on product type, technology, application, end user and region.

Product Type:

The table-top devices from the product type segment are expected to dominate the vein illumination devices market with the highest market share

Table-top vein illumination devices are high-precision medical devices used in hospitals, clinics, and blood donation centers to enhance vein visibility using infrared or near-infrared technology. They assist healthcare professionals in locating veins, especially for patients with difficult venous access, such as the elderly, obese individuals, and pediatric patients. Their stable imaging quality, hands-free operation, and suitability for prolonged procedures improve venipuncture success rates and patient comfort.

The increasing adoption of table-top vein illumination devices is driven by the increasing prevalence of chronic diseases, the growing elderly and pediatric populations with hard-to-locate veins, and advancements in infrared imaging technology. The demand for minimally invasive procedures, patient comfort, and reduced procedural errors is also driving the adoption of these devices. The increasing number of blood donation drives and surgical procedures worldwide supports market expansion.

Geographical Analysis

North America is expected to hold a significant position in the vein illumination devices market with the highest market share

The North America vein illumination devices market is fueled by chronic diseases like diabetes, cardiovascular disorders, and obesity, which often cause difficult venous access. The growing demand for accurate venipuncture procedures in hospitals and clinics is driving market growth. Strong healthcare infrastructure and advanced medical technologies, along with the rising prevalence of chronic diseases in the U.S. and Canada, support the widespread integration of vein illumination devices.

For instance, according to the National Institute of Health, approximately 82.6 million people in the United States currently have one or more forms of cardiovascular disease (CVD), making it a leading cause of death for both men and women. Common types of cardiovascular disease include coronary heart disease (CHD), stroke, hypertension, and congestive heart failure. An estimated 16.3 million Americans aged 20 and older have CHD, a prevalence of 7 percent.

Competitive Landscape

The major global players in the vein illumination devices market include AccuVein Inc, Christie Medical Holdings, Inc, TransLite LLC, BLZ Technology Inc, VeinSight, Near Infrared Imaging, Inc, Cambridge Medical (Venoscope), VueTek Scientific LLC, and NextVein LLC, among others.

Key Developments

  • In December 2023, Polymatech Electronics introduced the vein detection light, a medical device that offers high-definition vein detection. The device provides real-time full HD visualisation of subdermal veins, ensuring clarity. The device weighs only five pounds and is designed for mobility, making it convenient for healthcare professionals to use in various medical settings. This technology is expected to revolutionize the healthcare industry.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global vein illumination devices market report delivers a detailed analysis with 70 key tables, more than 74 visually impactful figures and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by Application
  • 2.6. Snippet by End User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Growing Demand for Minimally Invasive Procedures
      • 3.1.1.2. Surge in Demand for Point-of-Care and Home Healthcare Settings
    • 3.1.2. Restraints
      • 3.1.2.1. Limited Awareness and Training Among Healthcare Professionals
      • 3.1.2.2. High Cost of Advanced Vein Illumination Devices
    • 3.1.3. Opportunity
      • 3.1.3.1. Integration of AI and Infrared Technology for Improved Accuracy
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. South America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Table-top Devices*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Hand-held Devices

6. By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. Near-Infrared (NIR) Technology*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Transillumination Technology
  • 6.4. Ultrasound Technology

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Venipuncture Assistance*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. IV Access
  • 7.4. Blood Draw
  • 7.5. Others

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals & Clinics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Blood Donation Centers
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Academic & Research Institutions

9. Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. AccuVein Inc*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Christie Medical Holdings, Inc
  • 11.3. TransLite LLC
  • 11.4. BLZ Technology Inc
  • 11.5. VeinSight
  • 11.6. Near Infrared Imaging, Inc.
  • 11.7. Cambridge Medical (Venoscope)
  • 11.8. VueTek Scientific LLC
  • 11.9. NextVein LLC

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us